Healthcare + Hospitals

GE HealthCare’s HelloAI delivers 20+ hours of free, on-demand AI training for clinicians, researchers and leaders to build practical AI fluency and responsible use.

How AI is cutting drug discovery timelines: target identification, molecule design, toxicity prediction, and regulatory issues shaping faster therapies.

NHS Shared Business Services unveils a £900m AI procurement framework (2027-2035) to buy diagnostics, analytics and robotics tech, while sparking spending debate.

How AI is improving medical imaging for earlier, more accurate diagnoses. Learn about performance gains, patient benefits, and what comes next in clinical use.

Practical strategies for healthcare leaders to build patient trust in AI: transparency, strong data governance, clinician communication, patient-centered design, and human-AI collaboration.

Explore how Pfizer, Tempus AI and Medtronic apply artificial intelligence across drug R&D, precision medicine and medical devices to transform care.

Mayo Clinic’s radiomics AI flags pancreatic cancer up to 3 years earlier using routine CT scans. What this means for early diagnosis, barriers to rollout, and scalable solutions.

A concise overview of AI’s clinical and research potential, key risks like bias and privacy, and how regulators and industry groups are shaping responsible adoption.

A concise, balanced overview of where AI can help medicine today, the technical and ethical obstacles, and practical steps for responsible adoption.

A University of Würzburg study in Nature Health finds patients report less detail to AI symptom checkers. Design tactics for better patient-AI dialogs.